Standout Papers

Assessment of Liver Function in Pa... 1993 2026 2004 2015 1.7k
  1. Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade (2014)
    Philip J. Johnson, Sarah Berhane et al. Journal of Clinical Oncology
  2. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study (2015)
    Joong‐Won Park, Minshan Chen et al. Liver International
  3. Meeting report: International autoimmune hepatitis group (1993)
    Philip J. Johnson, Ian G. McFarlane Hepatology
  4. Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection (2018)
    Anthony W.H. Chan, Jian‐Hong Zhong et al. Journal of Hepatology
  5. Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial (2017)
    Tim Meyer, Richard Fox et al. ˜The œLancet. Gastroenterology & hepatology
  6. The role of hepatic resection in the treatment of hepatocellular cancer (2015)
    Sasan Roayaie, Ghalib Jibara et al. Hepatology
  7. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma (2022)
    Philip J. Johnson, Qing Zhou et al. Nature Reviews Gastroenterology & Hepatology

Immediate Impact

5 by Nobel laureates 1 from Science/Nature 134 standout
Sub-graph 1 of 14

Citing Papers

Hypoxia-tropic delivery of nanozymes targeting transferrin receptor 1 for nasopharyngeal carcinoma radiotherapy sensitization
2025 Standout
Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial
2022 Standout
61 intermediate papers

Works of Philip J. Johnson being referenced

Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
2015 Standout
Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
2002
and 22 more

Author Peers

Author Last Decade Papers Cites
Philip J. Johnson 11341 8348 5686 311 21.0k
Winnie Yeo 7117 5846 6315 417 17.2k
Keizō Sugimachi 6467 3967 6588 874 24.8k
Ken Shirabe 8017 4698 4735 846 16.9k
Alan P. Venook 5085 3480 9629 361 17.1k
Chris Verslype 5995 3564 7097 332 15.0k
Hys Ngan 2660 4202 4021 506 20.9k
Anthony T.�C. Chan 2301 2760 11344 453 26.8k
Michel Ducreux 7433 7308 25207 612 36.6k
Paul B.S. Lai 6157 4704 5978 428 20.6k
John Primrose 4252 1219 6860 227 12.5k

All Works

Loading papers...

Rankless by CCL
2026